Lee Cronin’s The Mummy Worldwide Box Office: Can It Outgross Saw III, The Highest-Grossing Film In The Saw Franchise?

Why It Matters

The box‑office race underscores the commercial viability of original horror IPs versus entrenched franchises, shaping studio budgeting and distribution strategies for the rest of 2026.

Key Takeaways

• The Mummy earned $119.4M worldwide in two weeks.
• Needs $45.5M more to outgross Saw III’s $164.9M.
• Scream 7 leads 2026 horror with $207.6M global haul.
• Upcoming titles like Evil Dead Burn could erode its momentum.
• Strong overseas performance, especially in Europe, Mexico, India.

Pulse Analysis

The horror genre has enjoyed a surprisingly robust 2026, with several titles breaking past the $100 million mark. Lee Cronin’s The Mummy, a fresh take on the classic monster mythos, has amassed $119.4 million worldwide after just two weeks, securing the No. 2 slot behind Scream 7’s $207.6 million. Unlike franchise stalwarts, Cronin’s film relies on a blend of atmospheric dread and a modern narrative hook, proving that new intellectual property can still attract sizable theater audiences in a market dominated by sequels and reboots.

Despite its solid start—$25.8 million domestically and $93.6 million abroad—the film faces a steep climb to eclipse Saw III, the highest‑grossing entry in the long‑running slasher series, which sits at $164.9 million. Closing a $45.5 million gap will require sustained momentum in key overseas territories such as Europe, Mexico, and the rapidly expanding Indian market. However, the calendar is quickly filling with heavyweight releases like Evil Dead Burn, Insidious 6, and a new Resident Evil installment, all of which could siphon away the remaining audience.

The outcome matters for studios weighing the risk‑reward balance between original horror concepts and proven franchises. A successful push past Saw III would reinforce confidence in green‑lighting fresh horror scripts, potentially reshaping budget allocations for the remainder of the year. Conversely, if The Mummy stalls, it may accelerate the industry’s tilt toward franchise extensions, where brand recognition already guarantees a baseline box‑office. Investors and distributors will be watching the next three weeks closely, as the film’s trajectory could set a benchmark for 2026’s horror economics.